August 2023 FDA Recall Drug by Inmar Supply Chain Solutions, Llc
D-1104-2023 - CGMP Deviations

This Class II drug recall was initiated by Inmar Supply Chain Solutions, Llc on August 14, 2023 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown. and the recall is currently ongoing.

Recall Number: D-1104-2023

Reason for Recall
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Initiated
08-14-2023
Reported
08-30-2023
Quantity
Unknown

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Inmar Supply Chain Solutions, LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Batch or Lot Expiration Information

Lot# Miscellaneous